Cerebrotendinous Xanthomatosis Market is driven by Diagnostic Advances

a adăugat un sunet Alte

2025-05-26 08:25:16 -

The Cerebrotendinous Xanthomatosis Market encompasses therapies and diagnostic tools aimed at treating a rare, inherited lipid storage disorder characterized by abnormal cholesterol and cholestanol accumulation in tissues. Key products include chenodeoxycholic acid (CDCA) formulations, novel bile acid analogs, substrate reduction therapies and emerging gene therapies. These interventions offer...

0 Commentarii 0 Distribuiri 528 Views 0 previzualizare